Latest news
Vir Biotechnology 2Q 2026: Revenue $238.95M, Net income $80.08M, EPS $0.47— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:31:01 GMTVIR: Q2 2026 net income reached $80.1M, fueled by Astellas collaboration and clinical progress - TradingViewTradingView · Wed, 05 Aug 2026 20:21:15 GMTVIR: Q2 2026 delivered record revenue, profitability, and major clinical and partnership milestones - TradingViewTradingView · Wed, 05 Aug 2026 20:14:31 GMTVir Biotechnology posts $238.9M Q2 revenue, $80.1M net income; $1.01B cash runway into H2 2028 - TradingViewTradingView · Wed, 05 Aug 2026 20:13:01 GMTEarnings To Watch: Vir Biotechnology Inc (VIR) Q2 2026 -- GF Value Sees 175% Upside - Yahoo FinanceYahoo Finance · Tue, 04 Aug 2026 13:40:33 GMTVIR Aug 2026 9.000 put (VIR260821P00009000) stock price, news, quote and history - Yahoo Finance SingaporeYahoo Finance Singapore · Mon, 03 Aug 2026 05:30:36 GMTVirseker Noordvaal Cup Series – 1 August Fixtures - SA School SportsSA School Sports · Thu, 30 Jul 2026 11:30:12 GMT